US Stock MarketDetailed Quotes

RMD ResMed

Watchlist

230.600
+0.390+0.17%

Trading Dec 19 12:04 ET

33.85BMarket Cap30.58P/E (TTM)

ResMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ResMed Q1 2025 Earnings Date

Currency：USDOct 24, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	1.18B	1.22B	+41.58M
Beat Est.	+7.31%	+11.08%	+3.52%
EPS	1.95	2.11	+0.16
Beat Est.	+31.16%	+41.61%	+7.97%

Analyst Rating

Buy

Dec 19, 2024

ResMed Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q3	-- / 1.298B	--
--	2025/Q2	-- / 1.272B	--
Oct 24, 2024	2025/Q1	1.225B / 1.183B	--
Aug 1, 2024	2024/Q4	1.223B / 1.214B	--
--	2024/Q3	1.197B / 1.172B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q3-- / 1.298B--

--2025/Q2-- / 1.272B--

Oct 24, 20242025/Q11.225B / 1.183B--

Aug 1, 20242024/Q41.223B / 1.214B--

--2024/Q31.197B / 1.172B--

Unlock Free Earnings Estimates

Open Account

ResMed Earnings Reports

10-Q: Q1 2025 Earnings Report

Oct 25 16:20 ET

8-K: ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025

Oct 24 16:10 ET

10-K: FY2024 Annual Report

Aug 9 15:50 ET

8-K: ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024

Aug 1 16:07 ET

Trending US Stocks

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

DMZPY

+3.16%

Halozyme Therapeutics

Collegium Pharmaceutical

COLL

+1.20%

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 19, 2024

Buy

Buy
60.00%
Hold
40.00%
Sell
0.00%

Price Target

No Data